The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C01 | Cardiac therapy | |
| 3 | C01D | Vasodilators used in cardiac diseases | |
| 4 | C01DX | Other vasodilators used in cardiac diseases | |
| 5 | C01DX12 | Molsidomine |
| Active Ingredient | Description | |
|---|---|---|
| Molsidomine |
Molsidomine is a long acting vasodilating drug. Molsidomine, a sydnonimine acting as a heterocyclic direct nitric oxide donor, has been used for the treatment of patients with stable angina pectoris. It’s also established drug for the treatment of coronary heart disease. Molsidomine is metabolized in the liver to the active metabolite linsidomine. Linsidomine is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound. |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
